# THC THERAPEUTICS, INC. · Edgar & Edgarette company card

> Thc Therapeutics reported revenue of $0 million in FY2024, operating margin null against a 9.7% median for farm machinery & equipment, equity -35702% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1404935 · fiscal year ended 2024-07-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/1404935) · [JSON](https://www.pops4.com/boards/company/1404935.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $0 |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | -Infinity% (prior year -Infinity%) |
| Net margin | -Infinity% |
| Operating cash flow | −$183,273 |
| Capital spending | — |
| Free cash flow | — |
| Cash | $35 |
| Long-term debt | — |
| Total assets | $10,648 |
| Total equity | −$4M |
| Equity ÷ assets | -35702.1% |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -14704.06 (distress zone)
- Piotroski F: 2 of 9 (weak)
- Health Harbor boat: Old boat · three warning signs · liabilities exceed assets (often from years of share buybacks, not always distress); operating cash flow was negative (-$183K in FY2024); operating loss: a margin of -Infinity% in FY2024

## Edgarette's reading

Exposure: revenue $0K (FY2024). Experience: one year on record; operating margin null, up from null. Soundness: equity -35702.1% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Against peers (108 filers, $50M+ revenue, its industry group): operating margin null against a 9.7% median.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 8-K · filed 2026-10-30 · 1.02 Termination of a Material Definitive Agreement; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1404935/000147793226006561/0001477932-26-006561-index.htm)
- 10-K · filed 2026-02-27 · [filing](https://www.sec.gov/Archives/edgar/data/1404935/000147793226001083/0001477932-26-001083-index.htm)
- 8-K · filed 2025-07-17 · 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1404935/000147793225005094/0001477932-25-005094-index.htm)
- 8-K · filed 2025-06-27 · 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1404935/000147793225004827/0001477932-25-004827-index.htm)
- 8-K · filed 2025-04-09 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1404935/000147793225002557/0001477932-25-002557-index.htm)
- 10-Q · filed 2024-11-13 · [filing](https://www.sec.gov/Archives/edgar/data/1404935/000147793224007106/0001477932-24-007106-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001404935.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1404935

## Cite

POPS4, Edgar & Edgarette: THC THERAPEUTICS, INC. company card, from the company's own SEC filings, accessed 2026-11-02, https://www.pops4.com/boards/company/1404935. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.